The Ecology, Epidemiology, Pathogenesis, and Diagnosis of MERS Coronavirus

October 2018 

 

Registration will open in August 2018
Members: Free 
Non-Members: $100

 

1.0 P.A.C.E.® Contact Hour
PASCV is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. 


Moderator:
Ryan Relich, Ph.D.; Indiana University Health Pathology Laboratory, Indianapolis, IN

Speaker:
Neeltje van Doremalen, Ph.D.; NIH, Hamilton, MT
 
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel zoonotic pathogen that emerged in the human population in 2012. Since that time, MERS-CoV has been implicated in numerous human infections, and case fatality rates have hovered around 40%. Many questions regarding this pathogen’s origins, ecology, and pathogenesis remain unanswered, but research has revealed many interesting aspects of the biology of MERS-CoV. In this webinar, Dr. Neeltje van Doremalen (Rocky Mountain Laboratories, NIH), will discuss the known history of MERS-CoV and will provide an update on what is currently known about the ecology, epidemiology, diagnosis, and pathogenesis of this emerging pathogen.
 
Upon completion of the webinar, the participant should be able to: 

  • Discuss how MERS-CoV was discovered and list methods that were employed by virologists to identify it; 
  • Describe known routes of transmission of MERS-CoV from animals to human hosts and compare clinical features of MERS-CoV infection in both dromedary camels and humans; 
  • Identify factors that are important in the pathogenesis of MERS-CoV infection, including, for example, the distribution of its cellular receptor DPP4; and 
  • Outline diagnostic, treatment, and prevention strategies that are being researched to combat infections caused by MERS-CoV.

 

Level: Intermediate

 

Association Management Software Powered by YourMembership  ::  Legal